FDA Inspection 1120694 — Fotios Loupakis, M.D., Ph.D
The FDA completed an inspection of Fotios Loupakis, M.D., Ph.D on February 14, 2020 in Padova. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Padova (Italy)
Additional Details
Clinical Investigator (CI)